Visit us

14F, Oriental-Weiye Square, No.609 Yinxiang Road, Jiading District, Shanghai, PR.CHINA

Email us

beyondbiotech@126.com beyondbiotech@163.com

Call us

Tel:+86 021-60959250              Mob:+8618516129136                                15901864269
Whatsapp:+86 15901864269

LATEST PRODUCT

Instruments

Reagents

Consumables

Lab wares

Reagents

Instruments

Instruments

About Us

Beyondbio-Tech is located in the biggest city of China—Shanghai. It is a professional engaged in Bio-reagents, Bio-raw materials, IVD products, laboratory instruments, and medical equipment for R&D, production, sales and services enterprises. BT company has 5 major characteristic product series: molecular POCT instruments, lyophilzed reagents, nano magnetic beads, enzyme raw materials, and disposable plastic consumables.
 
Beyondbio-Tech has been focusing on providing the best bio-products for life science researchers all over the world. Beyondbio-Tech products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc. Beyondbio-Tech now has hundreds of products include Bio-reagents, Bio-raw Materials,  IVD instruments and kits, Extraction  kits, PCR Master Mix, Genotyping kits, FISH Probe Kits,  and Lab Equipments. Beyondbio-Tech can provide the overall solution of Bio-products based on our technology Platforms. Beyond bio Tech's customers come from hospitals, universities, national research institutions, medical laboratories, CRO companies, biopharmaceutical companies, and more.
 
Our mission is to provide the best quality products and to develop novel technologies that assist researchers to find solutions in quest of scientific achievements. Becuse of the world-class leading technology, we are popular in domestic and overseas markets. Driven by desires to improve life quality and achieve scientific excellence, we operate with the highest standards of integrity.
 
Adhering to the enterprise spirit of " Responsible, User experienc, Professional innovation, pragmatic and efficient ", Beyondbio-Tech products are serving the global market wholeheartedly. Excellent products and services derives from professionalism. It is our goal to become the best solution provider for both research laboratory and IVD.
 
Looking forward to Cooperate with you.
 

View More

Functional micro nano materials have extensive applications in biomedical fields such as in vitro diagnosis, molecular imaging, and disease treatment due to their rich optical, electrical, magnetic properties, and good biocompatibility. Through years of research and development accumulation and industrial application, we have successfully built three innovative research and development platforms and application solutions around micro and nano material technology.
1.Multiple raw materials available, various packaging forms, and compatible with multiple platforms; 2.Add an appropriate amount of primers/probes and templates to test; 3.By providing the solution ratio for your testing, you can produce your fully premixed lyophilized reagents as needed. 4.Long term stability verification: 5 years at room temperature. Thermal stability verification: No change in performance at 50 ℃ for one month
In the current field of life sciences, it is usually necessary for polymer materials to have hydrophilic, hydrophobic, temperature sensitive response and other characteristics on their surfaces to endow them with biocompatibility and adapt to the development needs of the biopharmaceutical industry. The commonly used surface modification technologies for polymer materials in the field of life sciences mainly include plasma treatment, plasma grafting polymerization.
1. Fully automated molecular POCT 2. On machine selection, random access 3. Modularization, independent operation of multiple projects
The demand for simple, fast, accurate, and compatible molecular diagnostic POCT products will continue to expand in the context of future human outbreaks, animal disease testing, and other situations.LAMP, also known as Loop mediated Isothermal Amplification, is a type of isothermal amplification technology that does not require temperature fluctuations and has a low dependence on instruments. By adding visual dyes, the results can be directly observed with the naked eye.

Life Sciences: Bringing Hope to Humanity

Request a Quick Quote

OUR RECENT NEWS

August 03,2026
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026.
December 12,2025
Western drug executives long treated China as little more than a sales target. Think more than a billion potential customers, a gold mine for revenue, but nothing special in terms of fresh ideas. Lately, that thinking has changed fast.
July 27,2026
Roche received FDA 510(k) clearance for its cobas® BV/CV assay, a molecular diagnostic test that detects Bacterial vaginosis and Candida vaginitis from a single vaginal swab. Traditional methods like microscopy have nearly 50% misdiagnosis rates. The PCR-based test improves accuracy, aligning with CDC guidelines. It integrates with Roche's sexual-health portfolio, enabling concurrent STI testing from one sample. Bacterial vaginosis affects ~27% of North American women of reproductive age.
July 28,2026
The U.S. FDA has approved Freenome's SimpleScreen CRC, a blood-based screening test for colorectal cancer in adults aged 45 and older—the company's first commercial product. Partner Abbott will exclusively commercialize it in the U.S. starting this fall, competing with Guardant Health's Shield test. The test detects cancer signals from circulating DNA fragments. In a 48,000-person study, it showed 81.1% sensitivity for colorectal cancer and 13.7% for advanced precancerous growths
June 23,2026
Two new complementary initiatives from CIDRAP’s Vaccine Integrity Project and The Evidence Collective aim to evaluate and improve US vaccine policymaking, governance, and public trust amid ongoing changes to the nation's immunization infrastructure.
July 29,2026
Bristol Myers Squibb is deploying an NVIDIA DGX SuperPOD with eight Vera Rubin NVL72 racks (576 Rubin GPUs), claiming it as life sciences' most powerful single-owned AI infrastructure. This follows Lilly's October 2025 supercomputer and Roche's March 2026 AI factory. BMS, which has operated a DGX SuperPOD since 2024, is expanding and combining systems. The new cluster offers ~10.1 exaflops peak dense FP8 training performance and 166 TB memory.
March 18,2026
With less than one month remaining before its official opening, the 23rd China International In Vitro Diagnostics by CACLP, together with a series of academic conferences, industry forums, and business meetings, has entered its final countdown stage. As the last official press release ahead of the event, this update outlines the latest developments of the exhibition, its expanding international engagement, and the key value it will deliver to the global diagnostics community.
April 30,2026
Over the past 16 months, Chinese biotechs have featured in ~6 of every 26 major pharma deals, accounting for nearly one-third of total value. Major licensing pacts include Merck with Hansoh and Hengrui, Pfizer with 3SBio, AstraZeneca with CSPC (twice), AbbVie with RemeGen, Sanofi with Sino Biopharm, and Lilly with Insilico. In 2025, China led global new drug launches for the first time, surpassing the U.S. McKinsey cites China’s R&D speed and cost advantages...
December 12,2025
erck & Co. remains the “big dog” in the pharma industry in 2025, with roughly $64.17 billion in FY2024 revenue. It claimed the top position a year earlier. Drawing on continued Keytruda momentum, which continues its reign as the world’s best-selling drug with sales that rose 18% to $29.5 billion in 2024. In all, Keytruda accounts for about 46% of Merck’s sales. While Keytruda dominates, Gardasil/Gardasil 9 remains a significant contributor despite a 3% sales dip. It brought in $8.6 billion in 20
CONTACT US
FirstName *
LastName *
Email *
Message *